“Haemophilus Influenzae Type B Polyribosylribitol Phosphate-Tetanus (Hib PRP-T) Vaccine Safety, Phase I Study”. 2015. International Journal of Integrated Health Sciences 3 (2): 55-59. https://doi.org/10.15850/ijihs.v3n2.584.